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We recently utilized the technique of resin hemoperfusion (employing an Amberlite XAD-4
resin cartridge) to remove drug from a patient in deep coma after an estimated ingestion of
greater than 4.5 grams of methaqualone. At plasma flow rates of 204 ml/min, the mean value
for plasma clearance of methaqualone was 179 ml/min. The amount of methaqualone
recovered from the cartridge at the end ofthe 10-hour procedure was 1,565 mg measured by gas
chromatography. The patient became responsive to deep pain by the end ofthe procedure. The
only complication encountered was a transient decrease in the formed blood elements. The
present study verifies that a large, pharmacologically significant quantity ofmethaqualone can
be removed in a short time using resin hemoperfusion.
The value of hemoperfusion in the treatment of acute drug poisoning has recently
been stressed [1-3], but caution has been advised against widespread use ofthis form
of therapy until its worth has been established [3,4]. It has been suggested that data
concerning clearance rates and total drug removal should be established for each
toxin and the results of hemoperfusion compared with conservative management
before this technique is assigned a major role in the therapy of drug overdose [3,4].
We recently had the opportunity to study a patient with a massive overdose of
methaqualone (Quaalude, Lemmon Pharmaceutical Company, Sellersville, PA). To
our knowledge, clinical data reporting both clearance values and amount of metha-
qualone removed with resin hemoperfusion have not yet been published. We present
this case to provide data on the use of resin hemoperfusion in methaqualone
overdose.
CASE REPORT
A 35-year-old man with a history of previous suicide attempts was admitted 48
hours after ingesting approximately 30-40 150 mg tablets of methaqualone. Al-
though breathing spontaneously, he showed no response to deep pain. BP = 180/90,
P = 110, T = 100.80F. His pupils were midplane and reactive, and corneal reflexes
were present. Except for this Stage III coma, the physical exam was otherwise
unremarkable. A methaqualone level drawn on admission was 9.8 ,ug/ml, 3-5 times
the concentration of 2-3 ,ug/ml seen with therapeutic doses [5,6].
Initially, an attempt was made to minimize absorption of the drug by gastric
lavage followed by instillation of activated charcoal. Respiratory function was
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All rights of reproduction in any form reserved.controlled with endotracheal intubation and mechanical ventilation and urinary
output was maintained at 200 ml/hour with intravenous fluids. Despite this conser-
vative therapy, he remained in deep coma. Spontaneous respirations became
intermittent and then ceased during the first few hours of hospitalization. In an
attempt to minimize the prolonged coma known to occur after ingestion of this
quantity of methaqualone [8], hemoperfusion was started six hours after admission,
using an Amberlite resin XAD4 cartridge (Extracorporeal Medical Specialties, Inc.,
King of Prussia, PA) and was continued for 10 hours. Blood samples for methaqua-
lone levels were obtained at three-hour intervals, spun immediately, and stored fro-
zen until analyzed. The patient became responsive to pain and developed spontane-
ous movements by the end of the procedure and was fully awake by the following
day.
MEASUREMENT OF METHAQUALONE
Analyses ofPlasma
Assays were performed on a Perkin Elmer 3920 gas chromatograph equipped with
a nitrogen detector, and 6 ft 3 percent OV-17 column. One ml of plasma (patient or
standard) was adjusted to pH 12 and extracted three times with 4 ml of hexane
containing 3 percent isoamyl alcohol. The pooled solvent extracts wereevaporated to
dryness under N2, reconstituted in hexane: ethyl acetate (2:1), and chromatographed
isothermally at 2400C. The internal standard (methodone) was added to the plasma
prior to extraction. Concentrations were determined using relative peak heights.
Analysis of Cartridge
A homogeneous slurry of the cartridge was prepared, and an exactly weighed
aliquot was removed, adjusted to pH 12 and successively extracted twelve times with
methanol:ethyl acetate (1:1). Each aliquot of solvent was supplemented with internal
standard and submitted to gas chromotography. The last three extractions were free
of methaqualone. Completeness of recovery was validated by extraction of XAD-4
resin to which a known quantity of methaqualone had been added.
RESULTS
During the ten hours of hemoperfusion, blood flow through the Amberlite column
averaged 300 ml/min, equivalent to a plasma flow rate of204ml/min(Hct = 32). The
mean extraction rate for methaqualone,
(arterial level - venous level xN100 arterial level
was 85 percent, and never fell below 75 percent. These two values yielded a mean
plasma clearance rate of 179 ml/min. Specifically, plasma clearance values fell
slightly, from 186 ml/min during hour 3 to 153 ml/min during hour 10. There was a
transient fall of white blood cell count, from 10,700 to 5,300, and of platelet count,
from 170,000 to 90,000. These returned to normal after the procedure. The hemato-
crit also dropped, from 37 to 31 vol percent, but this was not associated with
microangiopathic changes on peripheral smear. Serum calcium concentration did not
decrease. The amount of methaqualone recovered from the cartridge after 10 hours
was 1,565 mg.
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DISCUSSION
Methaqualone is a drug commonly ingested during street drug abuse and one
occasionally encountered in suicide attempts. Since the half life in the body is quite
long (36-74 hr) [7], prolonged coma is common with doses of greater than4.5 grams
[8]. Although mortality is usually low, death can result [8]. The drug is highly
protein-bound, very lipid-soluble, and metabolized mainly by the microsomal
enzymes in the liver [9]. Since only a small amount of the parent compound is
excreted unchanged in the urine [9], forced diuresis is an ineffective means of
increasing drug removal. Conventional dialysis techniques add little to the manage-
ment of these patients since clearance rates by both hemodialysis (29 ml/min) and
peritoneal dialyses (7.5 ml/hr) are low [10]. In contrast, data from one patient report
[11] and from studies in dogs [12] demonstrate that plasma clearance rates using
charcoal hemoperfusion are quite high (120-200 ml/min). In the present patient
study using an XAD-4 resin cartridge, a mean plasma clearance of 179 ml/min was
achieved. The amount of the drug removed from theAmberlite resin cartridge, 1,565
mg, was in excess ofthat which would be predicted from the plasma flow rates alone.
This suggests that methaqualone may be present in the red blood cell compartment
and that drug removal from whole blood may be greater than from plasma. As whole
blood levels of methaqualone were not measured in the present study, whole blood
clearances could not be calculated.
The procedure was well tolerated by the patient. As in previous studies, a transient
fall in formed blood elements was observed but most of these changes reverted to
normal after the procedure.
Hemoperfusion appears to be an effective method for the removal of methaqua-
lone. The decision to utilize this technique in a patient with methaqualone overdose
must be individualized, based on the approximate ingested dose, blood level, and
clinical condition. In this case, hemoperfusion was used because the patient was in
deep coma with a toxic blood level ofmethaqualone after the ingestion ofan amount
ofdrug known to produce prolonged coma. Although the correlation between blood
concentration of methaqualone and either level of consciousness or mortality is not
exact, concentrations above 8 ,g/ml are usually associated with coma[13] and death
has been reported with concentrations of 10-30 ,g/ml [14]. We could not establish
that the patient's outcome was significantly influenced by the use of hemoperfusion.
The present study does, however, verify that a large, pharmacologically significant
quantity ofmethaqualone can be removed in a short time using resin hemoperfusion.
Additional data are needed to document the amount ofdrugremoved, the risks ofthe
procedure, and the clinical course of patients treated with hemoperfusion following
methaqualone overdose before this therapy can be widely recommended.
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